CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Scientific Advice: Now offering responsiveness and flexibility in timelines

Published on: August 13, 2015
Result type: News

The CADTH Scientific Advice Program now offers a new level of responsiveness and flexibility to better meet the needs of the pharmaceutical industry. In the fast-paced and demanding environment of drug development, a one-size-fits-all approach simply isn’t optimal. Applicants may now inquire about:

  • customized timelines
  • more timely advice for smaller requests
  • obtaining advice at multiple time points along their early drug development plans.

We welcome your inquiries. Please contact us at to see how we can work with you to address your needs.